<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="92258">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01688154</url>
  </required_header>
  <id_info>
    <org_study_id>306724</org_study_id>
    <nct_id>NCT01688154</nct_id>
  </id_info>
  <brief_title>Ability of Grape Seed Proanthocyanidins to Reduce Postprandial Triglycerides in Humans</brief_title>
  <official_title>Ability of Grape Seed Proanthocyanidins to Reduce Postprandial Triglycerides in Humans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Technological Centre of Nutrition and Health, Spain</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Rovira i Virgili</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Universitari Sant Joan de Reus</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Technological Centre of Nutrition and Health, Spain</source>
  <oversight_info>
    <authority>Spain: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Grape seed proanthocyanidins have been reported to possess a hypotriglyceridemic effect
      after an acute or chronic consumption in rodents. In this study, we aimed to investigate the
      effects of an acute consumption of proanthocyanidins before a breakfast meal in humans.
      Moreover, the mechanisms implicated in the reduction of plasma triglycerides levels by grape
      seed proanthocyanidins in humans should be elucidated as well as its activity on vascular
      function.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The intervention will consist in the administration of 2 capsules containing the grape seed
      proanthocyanidins extract or 2 empty capsules (placebo) just before breakfast, which will
      consist of 100g of white bread, 75g of salami, 50g of fatty cheese, 125g of yogurt (10%
      fat), 25ml of olive oil and water ad libitum. The nutritional composition of this meal is as
      follows: 1.200 Kcal of energy content, 15% of energy from proteins, 22% from carbohydrates
      and 63% from fat (35% saturated fat), and 120mg of cholesterol. Blood samples will be taken
      at point 0.5,1,2,3 and 6 hours after breakfast. Moreover, urine samples will be collected at
      time 0 and 6 hours.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Actual">June 2013</completion_date>
  <primary_completion_date type="Actual">May 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>Area under the curve of plasma triglycerides concentration</measure>
    <time_frame>0-180 minutes</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>0-0.5-1-2-3-6 hours</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endothelial function (assessed by ischemic reactive hyperemia)</measure>
    <time_frame>0-0.5-1-2-3-6 hours</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood lipid levels, markers of inflammation and oxidation</measure>
    <time_frame>0-0.5-1-2-3-6 hours</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma levels of procyanidins metabolites</measure>
    <time_frame>0-0.5-1-2-3-6 hours</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Markers of cholesterol metabolism in PBMCs (mRNA and protein).</measure>
    <time_frame>0-0.5-1-2-3-6 hours</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Membrane lipid composition of erythrocytes and oxidation markers.</measure>
    <time_frame>0-0.5-1-2-3-6 hours</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non-targeted metabolomics and 8-epi-prostaglandin-F2α levels (in urine)</measure>
    <time_frame>0-6 hours</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Triglyceride Metabolism</condition>
  <condition>Cardiovascular Function</condition>
  <arm_group>
    <arm_group_label>Product 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>35 mg/Kg of grape seed proanthocyanidins extract (2 capsules)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control product</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>2 empty capsules</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>35 mg/Kg of grape seed proanthocyanidins extract (2 capsules)</intervention_name>
    <arm_group_label>Product 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>2 empty capsules</intervention_name>
    <arm_group_label>Control product</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults between the ages of 20 and 40

          -  Signing the informed consent

        Exclusion Criteria:

          -  Body mass index (BMI) lower than 18.5 or greater than 27 Kg/m2

          -  Smokers

          -  Regular medication

          -  Consumption of medication during the last week

          -  Following a weight-loss diet

          -  Vegetarians

          -  Abnormal glucose levels

          -  Diabetes

          -  Cardiovascular disease

          -  Gastrointestinal disease

          -  Anemia

          -  Nuts allergy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rosa Solà, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Rovira i Virgili</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maria Cinta Bladé, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Rovira i Virgili</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Technological Center of Nutrition and Health (CTNS)</name>
      <address>
        <city>Reus</city>
        <state>Tarragona</state>
        <zip>43204</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CTNS</name>
      <address>
        <city>Reus</city>
        <state>Tarragona</state>
        <zip>43204</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 2, 2013</lastchanged_date>
  <firstreceived_date>September 14, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Proanthocyanidin</mesh_term>
    <mesh_term>Procyanidin</mesh_term>
    <mesh_term>Grape Seed Extract</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
